Navigation Links
ARCA Discovery, Inc. to Present at 26th Annual JPMorgan Healthcare Conference on January 8, 2008
Date:1/4/2008

DENVER, Jan. 4 /PRNewswire/ -- ARCA Discovery Inc., a privately held biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced Richard B. Brewer, President and Chief Executive Officer, will present at the 26th Annual JPMorgan Healthcare Conference on Tuesday, January 8 at 2:00 PM PT.

The JPMorgan Healthcare Conference will be held January 7-10, 2008 at the Westin St. Francis in San Francisco, California.

About ARCA Discovery, Inc.

ARCA Discovery, Inc. is a privately-held biopharmaceutical company based in Denver, Colorado developing genetically-targeted therapies for heart failure and other cardiovascular diseases. The Company's first product is bucindolol, a next generation beta-blocker for chronic heart failure, which promises to be the first personalized, genetically-targeted cardiovascular therapy. ARCA plans to file for FDA approval of bucindolol in 2008, and to leverage its platform to develop other pharmacogenetic therapies for cardiovascular diseases. The Company recently closed a Series B round of $18 million, led by new investors Skyline Ventures and InterWest Partners. ARCA completed a $15 million Series A round in 2006 led by Atlas Venture and Boulder Ventures, which also participated in the Series B round.

About Bucindolol

ARCA has exclusive worldwide rights to bucindolol, a next generation beta-blocker for chronic heart failure. ARCA's cardiovascular platform combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development, in a unique approach that enables the efficient identification of pharmacogenetic targets. Applying this approach to bucindolol, ARCA has identified pathways affecting bucindolol response that are modulated by common genetic variations. This discovery is supported by substantial Phase 3 data, and will allow a physician to determine whether bucindolol is the right therapy for a pati
'/>"/>

SOURCE ARCA Discovery Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
2. deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference
3. QuatRx Pharmaceuticals to Present at 26th Annual JP Morgan Healthcare Conference
4. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
5. AutoGenomics Invited to Present at the JPMorgan Healthcare Conference
6. Thermage, Inc. to Present at the 10th Annual Needham & Company Growth Conference
7. Advanced Life Sciences to Present at Biodefense Session of 26th Annual JPMorgan Healthcare Conference
8. Cambrex Presentation at the JPMorgan Healthcare Conference to be Webcast
9. Xoft to Present at the 26th Annual JPMorgan Healthcare Conference
10. Danaher to Present at J.P. Morgan Healthcare Conference
11. Ikaria to Present at 26th Annual JPMorgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... NY (PRWEB) May 23, 2013 ... GRAPHALLOY® self-lubricating bushings mounted in stainless steel ... self-lubricating properties of GRAPHALLOY with the application and ... Stainless Steel Pillow Blocks work exceptionally well ... corrosive or hostile liquids such as acids, alkalies, ...
(Date:5/23/2013)... 2013 PI’s new LPS-24 positioners ... 15 mm travel range with closed-loop sensor resolution ... make these new positioners the ideal choice for ... rated version is also available. , More ... can be found at: , http://www.physikinstrumente.com/en/products/prdetail.php?sortnr=1000745&prw-lps24 ...
(Date:5/23/2013)... 23, 2013 On April 19th the ... supermarkets to search for the growing antibiotic resistant bacteria ... from a year long study were released late last ... specifically meats, over previous years. For those suffering from ... of antibiotic resistant bacteria in food, may eventually help ...
(Date:5/23/2013)...  Verenium Corporation (Nasdaq: VRNM ), a ... commercialization of high-performance enzymes, today announced that ... at two upcoming conferences. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO ... Second Annual Marcum LLP Microcap Conference on Thursday, May ... York City.  The presentation is scheduled to begin at ...
Breaking Biology Technology:Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3
... April 3, 2012 What,s a great idea worth? For ... Time Warner Cable, the answer is more than cash prizes, ... leaders. Students will also win patent assistance and space for ... business incubators. (Logo: http://photos.prnewswire.com/prnh/20091027/NY99197LOGO ) ...
... April 2, 2012 Grammy ® -nominated singer, songwriter, ... Biotech, Inc. are teaming up on Making Awareness ... a new program designed to raise awareness among African-American ... disproportionate impact on the African-American community.  With the highest ...
... CARLSBAD, Calif., April 1, 2012   Life Technologies Corporation ... across the spectrum of basic, translational and clinical cancer ... Annual Meeting 2012, taking place March 31 – April ... customers and collaborators will present research findings. ...
Cached Biology Technology:Big Ideas, Big Stakes 2Big Ideas, Big Stakes 3Big Ideas, Big Stakes 4Big Ideas, Big Stakes 5Charlie Wilson Teams Up With Janssen Biotech to Launch Making Awareness a Priority (M.A.P.) 2Charlie Wilson Teams Up With Janssen Biotech to Launch Making Awareness a Priority (M.A.P.) 3Charlie Wilson Teams Up With Janssen Biotech to Launch Making Awareness a Priority (M.A.P.) 4Charlie Wilson Teams Up With Janssen Biotech to Launch Making Awareness a Priority (M.A.P.) 5Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012 2Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012 3Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012 4Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012 5
(Date:5/22/2013)... engineering drastically reduces the time and effort needed ... of biotechnology, scientists are reporting. Published in the ... paves the way for more rapid development of ... other activities. , Keith Shearwin and colleagues explain ... genetic material DNA into a bacterium,s genome is ...
(Date:5/22/2013)... Legionella pneumophila bacteria is responsible for legionellosis, ... order to infect us, this pathogen has developed a ... unnoticed in our cells, thus avoiding these acting against ... biosciences research centre, CIC bioGUNE, in which teams from ... and the National Supercomputation Centre in Barcelona (BSC) have ...
(Date:5/22/2013)... and wild plants have slowed in recent years, according ... University of Leeds and the Naturalis Biodiversity Centre in ... the diversity of species in Britain, Belgium and the ... picture brightened markedly after 1990, with a slowdown in ... wild plants. , Professor Bill Kunin, Professor ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3
... In an unprecedented collaborative analysis published in the ... demonstrated that the ability of reef fish systems to ... the number of species. However, growing human populations hamper ... the most diverse reef fish systems suffer the greatest ...
... WEST LAFAYETTE, Ind. - A Purdue University biochemist has ... cancer drugs hit their targets, which may help reduce ... professor of biochemistry analytical chemistry, developed a nanopolymer that ... removed to determine which proteins in the cells the ...
... EULAR 2011 Press Registration is now open! ,You ... online by clicking here: www.eular.org/congress_press_registration.cfm ... is now available for information. The preliminary programme can ... www.eular.org/congress_session_prgrm.cfm Abstracts , Abstracts accepted ...
Cached Biology News:World's reef fishes tussling with human overpopulation 2World's reef fishes tussling with human overpopulation 3World's reef fishes tussling with human overpopulation 4Nanopolymer shows promise for helping reduce cancer side effects 2EULAR 2011 media update 2
Request Info...
...
Ultra-sensitive, non-radioactive detection of rat Osteopontin...
Agarose-LE, 250 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Biology Products: